Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China flag China · Delayed Price · Currency is CNY
4.150
+0.010 (0.24%)
Feb 4, 2026, 10:15 AM CST
6.68%
Market Cap5.66B +9.5%
Revenue (ttm)3.15B -25.5%
Net Income2.22M
EPS0.00
Shares Out1.37B
PE Ratio2,551.32
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,315,600
Average Volume24,323,448
Open4.220
Previous Close4.150
Day's Range4.110 - 4.220
52-Week Range3.660 - 6.940
Beta0.53
RSI32.49
Earnings DateApr 24, 2026

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headq... [Read more]

Sector Healthcare
Founded 1999
Employees 6,586
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002424
Full Company Profile

Financial Performance

Financial Statements